Edition:
India

Chiasma Inc (CHMA.OQ)

CHMA.OQ on NASDAQ Stock Exchange Global Select Market

1.65USD
23 Jan 2018
Change (% chg)

-- (--)
Prev Close
$1.65
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
12,918
52-wk High
$2.95
52-wk Low
$1.25

Select another date:

Mon, Jan 8 2018

BRIEF-Chiasma Announces Expected Year-End 2017 Cash And Investments Balance Of About $67 Mln

* CHIASMA INC - ANNOUNCES EXPECTED YEAR-END 2017 CASH AND INVESTMENTS BALANCE OF APPROXIMATELY $67 MILLION

BRIEF-Chiasma Q3 loss per share $0.28

* Chiasma Inc - ‍ cash, cash equivalents & marketable securities as of Sept 30, 2017 were $73.2 million, compared with $93.0 million as of December 31, 2016​ Source text for Eikon: Further company coverage:

BRIEF-Chiasma announces first patient is randomized in phase 3 trial of Octreotide capsules in patients with acromegaly

* Chiasma announces first patient is randomized in phase 3 chiasma optimal clinical trial of Octreotide capsules in patients with acromegaly

BRIEF-Chiasma reached deal with FDA on late-stage trial of its acromegaly drug

* Chiasma reaches agreement with FDA under special protocol assessment for a new phase 3 clinical trial of octreotide capsules in acromegaly

Select another date: